Log in to search using one of your social media accounts:

 

Merck KGaA, Pfizer's immunotherapy fails in lung cancer trial
FRANKFURT (Reuters) - Merck KGaA and Pfizer's cancer drug Bavencio could not be shown to improve survival in lung cancer patients that had previously undergone unsuccessful chemotherapy, Merck said. (Source: Reuters: Health)
Source: Reuters: Health - February 15, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Can our genes help predict how women respond to ovarian cancer treatment?
(Westmead Institute for Medical Research) New research, led by Professor Anna deFazio from the Westmead Institute and Westmead Hospital, has shown that the genes we inherit can have a significant impact on how the body processes chemotherapy drugs, which may lead to different clinical outcomes for ovarian cancer patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 15, 2018 Category: International Medicine & Public Health Source Type: news

For one early adopter, CAR T therapy means 18 months cancer-free and counting
For as long as he can remember, Josh Feldman has eagerly embraced the latest technology.Decades ago, his family was the first one on the block with a VCR. Years later, when television went hi-def, he acquired a big-screen TV and signed up for HD service.So after he was diagnosed with lymphoma, it was only natural that Feldman was driven to join clinical trials for a promising new treatment. He would become one of the first UCLA Health patients to receive CAR T therapy. When nothing else worked, the treatment beat back cancer and filled his life with new hope.“Years ago, while doing my own reading after my diagnosis, ...
Source: UCLA Newsroom: Health Sciences - February 14, 2018 Category: Universities & Medical Training Source Type: news

Only U.S. Cryotherapy Trial for Mesothelioma Finds Success
Thoracic surgeon Dr. Shanda Blackmon at the Mayo Clinic in Rochester, Minnesota, believes there is a place for cryotherapy in the future multidisciplinary treatment of pleural mesothelioma. She wants to show it with this groundbreaking clinical trial. “We think [cryotherapy] could play an important role in treatment,” Blackmon told Asbestos.com. “So far, things look promising, but you can’t say anything specific without more numbers. Right now, it’s a little like telling a story.” Cryotherapy involves destroying cancer cells, or any abnormal tissues, by freezing them with controlled nitr...
Source: Asbestos and Mesothelioma News - February 14, 2018 Category: Environmental Health Authors: Daniel King Tags: ADI-PEG 20 cryoablation cryotherapy intrapleural measles virus Mayo Clinic mesothelioma clinical trial Opdivo pacific mesothelioma center pleural mesothelioma pleuroscopy Shanda Blackmon Surgery for Mesothelioma After Radiation Thera Source Type: news

Cannabis over chemo: Woman says the oil cured her aggressive breast cancer in 5 months
(Natural News) When Dee Mani, now 44, was diagnosed with breast cancer last March, her doctors suggested chemotherapy. She originally agreed to undergo one year of the treatment for her triple negative breast cancer – the deadliest type – but later had second thoughts. After seeing her sister suffer and die after undergoing chemotherapy for... (Source: NaturalNews.com)
Source: NaturalNews.com - February 14, 2018 Category: Consumer Health News Source Type: news

Light-activated cancer drugs may minimize chemotherapy side effects
Chemotherapy drugs activated by light to treat cancer can minimize side effects by targeting only unhealthy cells, according to new research. (Source: Health News - UPI.com)
Source: Health News - UPI.com - February 13, 2018 Category: Consumer Health News Source Type: news

Light-activated cancer drugs without toxic side effects: fresh insight
Future cancer drugs that are activated by light and don’t cause the toxic side-effects of current chemotherapy treatments are closer to becoming a reality, thanks to new research made possible by the Monash Warwick Alliance, an intercontinental collaboration between the University of Warwick (UK) and Monash University (Australia). (Source: World Pharma News)
Source: World Pharma News - February 13, 2018 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Nivolumab immunotherapy safe, feasible during chemoradiation for adv. head and neck cancer
(American Society for Radiation Oncology) Analysis of a clinical trial, RTOG Foundation 3504, finds that nivolumab immunotherapy can be administered safely in conjunction with radiation therapy and chemotherapy for patients with newly diagnosed local-regionally advanced head and neck cancers. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 13, 2018 Category: International Medicine & Public Health Source Type: news

Light-activated cancer drugs without toxic side effects: Fresh insight
(University of Warwick) Future cancer drugs that are activated by light and don't cause the toxic side-effects of current chemotherapy treatments are closer to becoming a reality, thanks to new research made possible by the Monash Warwick Alliance, an intercontinental collaboration between the University of Warwick (UK) and Monash University (Australia). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 13, 2018 Category: International Medicine & Public Health Source Type: news

Lower-dose radiation effective, safe for HPV+ head & neck cancer after induction chemo
(American Society for Radiation Oncology) Results of the phase II OPTIMA clinical trial indicate that patients with head and neck cancers associated with the human papillomavirus (HPV), including those with advanced nodal disease, can receive substantially lower radiation doses safely and effectively if they respond to induction chemotherapy initially. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 13, 2018 Category: International Medicine & Public Health Source Type: news

Imaging system helps determine chemo efficacy against breast cancer
A new optical imaging system helps determine which breast cancer patients will best respond to chemotherapy, according to researchers at Columbia University. (Source: Health News - UPI.com)
Source: Health News - UPI.com - February 12, 2018 Category: Consumer Health News Source Type: news

NIR light may identify breast cancer patients who will benefit most from chemotherapy
(Columbia University School of Engineering and Applied Science) A new optical imaging system developed at Columbia University uses red and near-infrared light to identify breast cancer patients who will respond to chemotherapy. The imaging system may be able to predict response to chemotherapy as early as two weeks after beginning treatment. Findings from a first pilot study of the new imaging system -- a noninvasive method of measuring blood flow dynamics in response to a single breath hold -- were published today in Radiology. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 12, 2018 Category: International Medicine & Public Health Source Type: news

Targeting leukaemia with personalised treatment
EU-funded researchers are developing a personalised dosing solution for chemotherapy targeting leukaemia using advanced microfluidic chips to meet the precise medical requirements of individual patients. (Source: EUROPA - Research Information Centre)
Source: EUROPA - Research Information Centre - February 12, 2018 Category: Research Source Type: news

Patients with breast cancer live longer with soft chemo  
Traditional chemotherapy drugs can cause such severe side effects that they are often not given to older people in the late stages of cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - February 10, 2018 Category: Consumer Health News Source Type: news

Can Microbubbles Deliver Gene Therapy?
An Italian diagnostic imaging company is teaming with a Chicago startup to study whether microbubbles can deliver personalized gene therapy to treat high LDL cholesterol. Microbubble technology, combined with contrast-enhanced ultrasound, has been used diagnostically for years and more recently has inspired research for treatment of disease. Milan-based Bracco Imaging, S.p.A. is working with Steven Feinstein, a professor of medicine at Rush University Medical Center and president of SonoGene, LLC to pursue the treatment possibilities further. A CEUS researcher, Feinstein is also co-president of the  International Cont...
Source: MDDI - February 9, 2018 Category: Medical Devices Authors: Nancy Crotti Tags: R & D Source Type: news

Scientists Create First Lab-Grown Human Eggs
U.K. researchers who created the first laboratory-grown human eggs say their achievement could lead to news ways to preserve the fertility of girls undergoing radiation or chemotherapy for cancer. (Source: WebMD Health)
Source: WebMD Health - February 9, 2018 Category: Consumer Health News Source Type: news

Soft chemotherapy is very effective in older patients when added to targeted treatment in an aggressive breast cancer subtype
(European Organisation for Research and Treatment of Cancer) A trial published todayin The Lancet Oncology, shows that, in older patients with HER2 positive metastatic breast cancer (an aggressive breast cancer subtype where the cancer has spread to other parts of the body), a combination of a 'soft' chemotherapy with antiHER2 therapy is highly active and has low toxicity, important in a frail population. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - February 9, 2018 Category: International Medicine & Public Health Source Type: news

Two Prostate Cancer Drugs Delay Spread of the Disease by Two Years
The treatments could help hundreds of thousands of men worldwide stave off pain and chemotherapy, but researchers don ’ t yet know if they will extend lives. (Source: NYT Health)
Source: NYT Health - February 8, 2018 Category: Consumer Health News Authors: PAM BELLUCK Tags: Prostate Cancer Source Type: news

chemoWave app offers patients support during chemotherapy
Following a soft launch last year, the chemoWave disease companion app has now been fully released for chemotherapy patients interested in better managing their care, symptoms, and side effects. (Source: mobihealthnews)
Source: mobihealthnews - February 8, 2018 Category: Information Technology Source Type: news

Waiting to Treat the Cancer
It would be a race between the leukemia returning and the insurance company approving the procedure that could keep it at bay permanently. (Source: NYT Health)
Source: NYT Health - February 8, 2018 Category: Consumer Health News Authors: MIKKAEL A. SEKERES, M.D. Tags: Leukemia Transplants Bone Marrow Health Insurance and Managed Care Chemotherapy Testicles Cancer Source Type: news

HDAC6 inhibitors protect against neuronal damage and have therapeutic potential
(VIB (the Flanders Institute for Biotechnology)) Inhibiting HDAC6 improves the structural stability of cells and protects against neuronal damage. Leuven research uncovered that targeting this mechanism could be a promising therapeutic approach for peripheral neuropathies, whether due to Charcot-Marie-Tooth disease (CMT) or as a side effect of chemotherapy. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 8, 2018 Category: International Medicine & Public Health Source Type: news

Researchers develop breakthrough technique to combat cancer drug resistance
(University of Maryland) The ability for cancer cells to develop resistance to chemotherapy drugs -- known as multi-drug resistance -- remains a leading cause for tumor recurrence and cancer metastasis, but recent findings offer hope that oncologists could one day direct cancer cells to 'turn off' their resistance capabilities. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 8, 2018 Category: International Medicine & Public Health Source Type: news

60-Year-Old Drug May Hold Clues To Stopping Spread Of Breast Cancer
One of the oldest chemotherapy drugs in the world may be able to stop breast cancer spreading, according to a new study. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - February 7, 2018 Category: Pharmaceuticals Authors: Victoria Forster, Contributor Source Type: news

Docetaxel for Prostate Cancer:'Win-Win-Win'Docetaxel for Prostate Cancer:'Win-Win-Win '
In both metastatic and nonmetastatic patients, the chemotherapy improved three important outcomes compared with previous standard of care.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 7, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Delayed cancer diagnosis leaves family with 'what ifs'
A grandfather faced delays for chemotherapy - only to find out his condition had become terminal. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - February 7, 2018 Category: Consumer Health News Source Type: news

Cardiff man's eight-month cancer treatment wait
A grandfather who faced delays for chemotherapy is told his condition is terminal. (Source: BBC News | Health | UK Edition)
Source: BBC News | Health | UK Edition - February 7, 2018 Category: Consumer Health News Source Type: news

Insight into chromatin therapies for breast cancer could aid personalized medicine
(Boston University School of Medicine) Most traditional chemotherapy for cancer has dangerous side effects, but new research is finding ways to develop 'targeted agents' that reduce the side effects and are better tailored to individual patient needs. While these innovations are exciting, a new study shows how certain cancer inhibitors need to be examined more carefully to better understand fine-grained effects and counter-effects, which could yield more effective and safer therapies. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 7, 2018 Category: Cancer & Oncology Source Type: news

Men with cancer live for 25% longer if given a drug early
British researchers showed men with the cancer live 25 per cent longer if given docetaxel – an established chemotherapy drug – early on in their treatment. (Source: the Mail online | Health)
Source: the Mail online | Health - February 7, 2018 Category: Consumer Health News Source Type: news

Supplements and Chemotherapy-Induced Peripheral Neuropathy Supplements and Chemotherapy-Induced Peripheral Neuropathy
Do multivitamins mitigate development of chemotherapy-induced peripheral neuropathy?Journal of the National Cancer Institute (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 6, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

'You could feel it in your veins, like how cold it was': Using paint and selfies to cope with chemo
After being diagnosed with Stage III breast cancer when she was just 24, Lauren Sylliboy said the enormity of her illness didn't hit her right away. But exactly 14 days after her first chemotherapy treatment, that changed. Her hair started falling out and Sylliboy said she looked in the mirror and realized her illness was showing. (Source: CBC | Health)
Source: CBC | Health - February 2, 2018 Category: Consumer Health News Tags: Radio/Unreserved Source Type: news

How Cancer Immunotherapy Is Getting Even Better
Last year, the Food and Drug Administration approved two new immunotherapies to treat certain leukemias and lymphomas. Now, in a study published in the New England Journal of Medicine, researchers detail who is most likely to benefit from the treatments, called CAR T cell therapy. CAR T cell therapy trains the body’s immune system to target and destroy cancer cells in the blood; scientists take people’s own immune cells (T cells) and genetically engineer them to seek out and destroy cancer cells. The immune system can then attack cancer cells in the same way it does bacteria and viruses, and the therapy can lea...
Source: TIME: Health - February 2, 2018 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized Cancer cancer cells cancer immunotherapy CAR T car t cell therapy car t gene therapy car t therapy cure for cancer healthytime leukemia leukemia treatments Source Type: news

Mother, 44, 'cures' cancer by taking cannabis oil
Dee Mani, 44, from Birmingham, refused chemotherapy when she was diagnosed with triple negative breast cancer - deemed the deadliest form - and instead opted to try CBD. (Source: the Mail online | Health)
Source: the Mail online | Health - February 1, 2018 Category: Consumer Health News Source Type: news

Breast cancer treatments can raise risk of heart disease, American Heart Association warns
The American Heart Association issued a stark warning Thursday for women with breast cancer: Life-saving therapies like chemotherapy and radiation can cause heart failure and other serious cardiac problems, sometimes years after treatment. The organization said patients and doctors shouldn’t avoid the treatments but instead take steps to prevent or minimize the cardiac risks. And […]Related:Social egg freezing is a numbers game that many women don’t understandFDA wants to curb abuse of Imodium, ‘the poor man’s methadone’This flu season is on track to be the worst in nearly a decade (Sou...
Source: Washington Post: To Your Health - February 1, 2018 Category: Consumer Health News Source Type: news

Human trials to start for cancer vaccine
The team at Stanford University - which made a widely-used chemotherapy - claims just one injection into one tumor triggers a full-body response, attacking all other tumors that may have spread. (Source: the Mail online | Health)
Source: the Mail online | Health - February 1, 2018 Category: Consumer Health News Source Type: news

Voices: After a Cancer Diagnosis, Playing the Odds
I could continue to obsess over cold facts, or I could choose to be present and enjoy all the beautiful moments that make life worth living. (Source: NYT Health)
Source: NYT Health - January 31, 2018 Category: Consumer Health News Authors: KATIE PALAY Tags: Hodgkin's Lymphoma Infertility Drugs (Pharmaceuticals) Headaches Epilepsy Anxiety and Stress Chemotherapy Statistics Source Type: news

New guidelines for breast cancer survivors push "cheap hormone pills" with horrible side effects like nausea, vomiting and uterine cancer
(Natural News) New, insidious cancer care guidelines were put forth by The United Kingdom’s National Institute for Health Care Excellence (NICE). The guidelines instruct breast cancer survivors to take cheap hormone pills on a daily basis for up to ten years following chemotherapy (if the patient survives the chemotherapy). The current recommendations suggest a steady... (Source: NaturalNews.com)
Source: NaturalNews.com - January 31, 2018 Category: Consumer Health News Source Type: news

Medical News Today: The end of toxic chemo? Blocking vitamin B-2 may stop cancer
New drug candidate may change chemotherapy as we know it; this compound stops cancer cells from spreading and has no toxic side effects, a new study shows. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 31, 2018 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

UCLA scientists use stem cells to study genetics of germ cell tumors
UCLA researchers have made new inroads into understanding germ cell tumors, a diverse and rare group of cancers that begin in germ cells — the cells that develop into sperm and eggs. The researchers developed a protocol to recreate germ cell tumor cells from stem cells and used the new model to study the genetics of the cancer.Their findings could point the way toward new drugs to treat germ cell tumors, which account for around 3 percent of all cases of childhood and adolescent cancer.The study, published in Stem Cell Research, was led by Amander Clark, a UCLA professor of molecular cell and developmental biology an...
Source: UCLA Newsroom: Health Sciences - January 29, 2018 Category: Universities & Medical Training Source Type: news

Majority of cancer survivors struggle to adjust post-treatment, new study reports
Vancouver-based Penelope Hedges went through six months of chemotherapy and successfully battled ovarian cancer, but found life after treatment to be an unexpected challenge. (Source: CBC | Health)
Source: CBC | Health - January 29, 2018 Category: Consumer Health News Tags: News/Canada/British Columbia Source Type: news

Study: Talc Pleurodesis a Viable Option for Mesothelioma
Some patients with mesothelioma should consider the less-invasive talc pleurodesis procedure instead of aggressive, tumor-removing surgery, based on recent research from doctors at Mount Sinai Hospital. Although talc pleurodesis is considered only palliative, survival time often is not significantly different between the two procedures, according to the study published by Journal of Thoracic Disease. “There should be comprehensive conversation with your physician about treatment options, not only about survival, but about quality of life,” Dr. Emanuela Taioli, department of thoracic surgery, Icahn School of Me...
Source: Asbestos and Mesothelioma News - January 29, 2018 Category: Environmental Health Authors: Daniel King Tags: Emanuela Taioli extrapleural pneumonectomy Institute for Translational Epidemiology Journal of Thoracic Disease Maaike van Gerwen mesothelioma surgery Mount Sinai Hospital pleural effusions pleural mesothelioma pleurectomy and decorticat Source Type: news

HealthWatch: Flu Virus Used To Treat Pancreatic Cancer In Mice
BOSTON (CBS) – Pancreatic cancer is a particularly aggressive and deadly cancer, but now researchers in London have developed a modified flu virus to target and kill tumor cells. The virus has an extra protein that binds pancreatic cancer cells and scientists found the modified virus was able to stop cancer growth in mice. Pancreatic cancer is often caught late and is incredibly hard to treat because it can quickly become resistant to treatment. For a variety of cancers, researchers have been turning to mutated viruses to search out and kill cancer cells while trying to avoid drug resistance. The virus appears to hav...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - January 25, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Local News Seen On WBZ-TV Syndicated Local Dr. Mallika Marshall flu virus pancreatic cancer HealthWatch Source Type: news

No Benefit With Bevacizumab Maintenance Therapy for Metastatic CRC During Chemo-Free Intervals
Adding bevacizumab maintenance therapy failed to improve outcomes compared with no treatment when administered during chemotherapy-free intervals to patients with metastatic colorectal cancer after induction chemotherapy. (Source: CancerNetwork)
Source: CancerNetwork - January 25, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Colorectal Cancer Gastrointestinal Cancer News Source Type: news

This Tiny Implant Can Deliver Medicine to Your Brain With the Push of a Button
(WASHINGTON) — Scientists have created a hair-thin implant that can drip medications deep into the brain by remote control and with pinpoint precision. Tested only in animals so far, if the device pans out it could mark a new approach to treating brain diseases — potentially reducing side effects by targeting only the hard-to-reach circuits that need care. “You could deliver things right to where you want, no matter the disease,” said Robert Langer, a professor at the Massachusetts Institute of Technology whose biomedical engineering team reported the research Wednesday. Stronger and safer treatment...
Source: TIME: Science - January 25, 2018 Category: Science Authors: Lauren Neergaard / AP Tags: Uncategorized APH healthytime medicine onetime Source Type: news

This Tiny Implant Can Deliver Medicine to Your Brain With the Push of a Button
(WASHINGTON) — Scientists have created a hair-thin implant that can drip medications deep into the brain by remote control and with pinpoint precision. Tested only in animals so far, if the device pans out it could mark a new approach to treating brain diseases — potentially reducing side effects by targeting only the hard-to-reach circuits that need care. “You could deliver things right to where you want, no matter the disease,” said Robert Langer, a professor at the Massachusetts Institute of Technology whose biomedical engineering team reported the research Wednesday. Stronger and safer treatment...
Source: TIME: Health - January 25, 2018 Category: Consumer Health News Authors: Lauren Neergaard / AP Tags: Uncategorized APH healthytime medicine onetime Source Type: news

Chemotherapy for advanced gastric cancer
Data from 64 RCTs in this Cochrane Review concludes chemotherapy improves survival (by additional 6.7months) compared to best supportive care, and combination chemotherapy improves survival (by an additional month) compared to single-agent 5-fluorouracil. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 25, 2018 Category: Consumer Health News Source Type: news

Chemotherapy
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - January 25, 2018 Category: General Medicine Source Type: news

Herbal Supplements May Be Dangerous When You Take Certain Prescription Drugs
A number of common herbal supplements, including green tea and Ginkgo biloba, can interact with prescription medications, according to a new research review published in the British Journal of Clinical Pharmacology. These interactions can make drugs less effective—and may even be dangerous or deadly. Doctors know that herbs can affect medication regimens, wrote the researchers, from the South African Medical Research Council, in their new paper. But because people often don’t disclose to their healthcare providers what over-the-counter drugs and supplements they’re taking, it’s difficult for scienti...
Source: TIME: Health - January 24, 2018 Category: Consumer Health News Authors: Amanda MacMillan Tags: Uncategorized are herbal supplements safe are supplements safe drug interactions drug side effects green tea healthytime herbal drugs medicine onetime supplement safety warfarin Source Type: news

ASCO Guideline Offers Recommendations for Management of Mesothelioma
ASCO recently released a clinical practice guideline on the treatment of malignant pleural mesothelioma, including recommendations on diagnosis, staging, and treatment with chemotherapy, surgical cytoreduction, and radiation therapy. (Source: CancerNetwork)
Source: CancerNetwork - January 24, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Lung Cancer Mesothelioma News Source Type: news

Nintedanib Moves Closer to Mesothelioma Standard of Care
The Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom granted early access designation to nintedanib for the treatment of pleural mesothelioma, a major step forward for patients diagnosed with the asbestos-related cancer. Nintedanib, marketed under the brand names Ofev and Vargatef, is a small-molecule enzyme inhibitor. In clinical trials, the drug has shown the ability to prevent mesothelioma cell growth and slow tumor spread (metastasis). “This is potentially quite significant,” Dr. Dean Fennell, chair of thoracic medical oncology at the University of Leicester and University Ho...
Source: Asbestos and Mesothelioma News - January 24, 2018 Category: Environmental Health Authors: Daniel King Tags: Dean Fennell FDA LUME-Meso clinical trial md anderson cancer center MHRA nintedanib Ofev pleural mesothelioma Promising Innovative Medicine rama balaraman UCSF Helen Diller Family Comprehensive Cancer Center University of Pittsburgh Source Type: news

Targeting bladder cancer's Achilles heel: stem cells
(Johns Hopkins Medicine) Two different proteins work separately as well as synergistically to feed a small pool of stem cells that help bladder cancer resist chemotherapy, research led by a Johns Hopkins Kimmel Cancer Center scientist suggests. The finding, published online in Cancer Research, could lead to new targets to fight this deadly disease and potentially other cancers as well. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 24, 2018 Category: Cancer & Oncology Source Type: news